159 related articles for article (PubMed ID: 32209402)
21. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
22. New piece in Alzheimer's puzzle.
Travis J
Science; 1993 Aug; 261(5123):828-9. PubMed ID: 8346434
[No Abstract] [Full Text] [Related]
23. Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer's disease.
Refolo LM; Fillit HM
J Mol Neurosci; 2004; 23(3):151-5. PubMed ID: 15181243
[TBL] [Abstract][Full Text] [Related]
24. Inconstant apolipoprotein E (ApoE)-like immunoreactivity in amyloid beta protein deposits: relationship with APOE genotype in aging brain and Alzheimer's disease.
Uchihara T; Duyckaerts C; Lazarini F; Mokhtari K; Seilhean D; Amouyel P; Hauw JJ
Acta Neuropathol; 1996 Aug; 92(2):180-5. PubMed ID: 8841664
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E and Alzheimer's disease.
Scott J
Lancet; 1993 Sep; 342(8873):696. PubMed ID: 8103818
[No Abstract] [Full Text] [Related]
26. Amyloid beta-protein, APOE genotype and head injury.
Nicoll JA; Roberts GW; Graham DI
Ann N Y Acad Sci; 1996 Jan; 777():271-5. PubMed ID: 8624097
[TBL] [Abstract][Full Text] [Related]
27. Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.
Mecca AP; Barcelos NM; Wang S; Brück A; Nabulsi N; Planeta-Wilson B; Nadelmann J; Benincasa AL; Ropchan J; Huang Y; Gelernter J; Van Ness PH; Carson RE; van Dyck CH
Neurobiol Aging; 2018 Jan; 61():207-214. PubMed ID: 29111487
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's disease and possible gene interaction.
St George-Hyslop P; McLachlan DC; Tsuda T; Rogaev E; Karlinsky H; Lippa CF; Pollen D
Science; 1994 Jan; 263(5146):537. PubMed ID: 8290965
[No Abstract] [Full Text] [Related]
29. Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland.
Bratosiewicz-Zapart J; Kłoszewska I; Sobów T; Liberski PP
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):221-2. PubMed ID: 9597090
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E and Alzheimer's disease.
Stephens D
J R Soc Health; 1996 Feb; 116(1):41-3. PubMed ID: 8683540
[No Abstract] [Full Text] [Related]
31. APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.
Prince JA; Zetterberg H; Andreasen N; Marcusson J; Blennow K
Neurology; 2004 Jun; 62(11):2116-8. PubMed ID: 15184629
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.
Beffert U; Cohn JS; Petit-Turcotte C; Tremblay M; Aumont N; Ramassamy C; Davignon J; Poirier J
Brain Res; 1999 Oct; 843(1-2):87-94. PubMed ID: 10528114
[TBL] [Abstract][Full Text] [Related]
33. Amyloid-beta-induced degeneration of human brain pericytes is dependent on the apolipoprotein E genotype.
Verbeek MM; Van Nostrand WE; Otte-Höller I; Wesseling P; De Waal RM
Ann N Y Acad Sci; 2000 Apr; 903():187-99. PubMed ID: 10818507
[TBL] [Abstract][Full Text] [Related]
34. Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women.
Corbo RM; Gambina G; Ulizzi L; Monini P; Broggio E; Rosano A; Scacchi R
Dement Geriatr Cogn Disord; 2007; 24(2):82-5. PubMed ID: 17565217
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer's disease.
Norrman J; Brookes AJ; Yates C; St Clair D
Br J Psychiatry; 1995 Oct; 167(4):533-6. PubMed ID: 8829725
[TBL] [Abstract][Full Text] [Related]
36. Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.
Ishii K; Tamaoka A; Mizusawa H; Shoji S; Ohtake T; Fraser PE; Takahashi H; Tsuji S; Gearing M; Mizutani T; Yamada S; Kato M; St George-Hyslop PH; Mirra SS; Mori H
Brain Res; 1997 Feb; 748(1-2):250-2. PubMed ID: 9067471
[TBL] [Abstract][Full Text] [Related]
37. [Apolipoprotein E polymorphism and Alzheimer disease].
van der Weide J; Steijns LS; Teepen JL; Noback WJ; Klaverwijden G
Tijdschr Gerontol Geriatr; 1996 Apr; 27(2):73-7. PubMed ID: 8669075
[TBL] [Abstract][Full Text] [Related]
38. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.
Nagy Z; Esiri MM; Jobst KA; Johnston C; Litchfield S; Sim E; Smith AD
Neuroscience; 1995 Dec; 69(3):757-61. PubMed ID: 8596645
[TBL] [Abstract][Full Text] [Related]
39. Alzheimer's disease: clinical implications of the apolipoprotein E genotype.
Farlow MR
Neurology; 1997 May; 48(5 Suppl 6):S30-4. PubMed ID: 9153158
[TBL] [Abstract][Full Text] [Related]
40. About the use of APOE in Alzheimer's disease studies.
Verpillat P; Margaritte-Jeannin P; Clerget-Darpoux F
Am J Med Genet; 1998 Mar; 81(2):195. PubMed ID: 9613862
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
